[Effect of oral solcoseryl administration on liver metabolism in patients with chronic liver diseases].
D000183:Actihaemyl / Q000008:administration & dosage*; D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000429:Alcohol Oxidoreductases / Q000097:blood; D000641:Ammonia / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002908:Chronic Disease; D005969:Glutamate Dehydrogenase / Q000097:blood; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy*; D008134:Long-Term Care; D012709:Serum Albumin / Q000378:metabolism; D014020:Tissue Extracts / Q000008:administration & dosage*
D012709:Serum Albumin; D014020:Tissue Extracts; D000183:Actihaemyl; D000641:Ammonia; D000429:Alcohol Oxidoreductases; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Untersuchungen über die Wirkung oraler Solcoseryl-Gaben auf den Leberstoffwechsel chronisch Leberkranker